Osiris Therapeutics, Inc. Announces Second Quarter 2013 Financial Results
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its results for the second quarter of 2013.
Help employers find you! Check out all the jobs and post your resume.
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its results for the second quarter of 2013.
Help employers find you! Check out all the jobs and post your resume.